Ferric Carboxymaltose Injection Market Application Analysis: Iron...

adicionou um novo artigo Health

2026-07-02 16:35:46 -

Ferric Carboxymaltose Injection Market Application Analysis: Iron Deficiency Anemia Leading Growth

The Ferric Carboxymaltose Injection Market derives substantial revenue from its iron deficiency anemia application segment, which accounted for 39.8% of total market share in 2024. This segment, valued at 225 USD Million in 2024 and projected to reach 525 USD Million by 2035, reflects the widespread clinical use of ferric carboxymaltose as a first-line treatment for moderate to severe iron...

0 Comentários 0 Compartilhamentos 20 Visualizações 0 Anterior